April 2022

Invitation to contribute towards a research topic entitled ‘Impact of COVID-19 on Cancer Care and Rehabilitation’

April 11, 2022

The purpose of this collection of papers is to showcase and share learning from those who have had experience of these changes including implementing the use of IT solutions and/or IT science to assist and improve clinical outcomes for patients.

The overarching theme for the research topic is impact of COVID-19 pandemic on cancer care.

 
Read more

ISOPP Immunotherapy Task Force Report

April 11, 2022

Submitted by Lynne Nakashima, Chair, ISOPP Immunotherapy Task Force

The ISOPP Immunotherapy Task Force has been hard at work since the fall of 2020, developing resources to assist oncology pharmacy practitioners in managing the care of patients on immunotherapy.

 
Read more

Immunotherapy Task Force Position Paper published

April 7, 2022

ISOPP Position Paper on the role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions:

The position paper developed by the Immunotherapy Task Force has been published online ahead of print by JOPP. View the paper on the ISOPP website here.

 
Read more

Revised ISOPP Standards of Practice

April 4, 2022

Hot off the press! The revised ISOPP Standards of Practice has been published.

The revised ISOPP Standards of Practice document has been published in the Journal of Oncology Pharmacy Practice and posted to ISOPP’s website.

 
Read more